CAM
DNMR

Cresset Asset Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Cresset Asset Management’s Portfolio DNMR Stock Details DNMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,752
Closed -$794K – 1930
2023
Q1 		$794K Buy
+5,752
New +$526K 0.02% 385

Other funds holding DNMR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Teramo Advisors Naples, Florida $529M AUM 20.59% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Cresset Asset Management's DNMR Position: Q2 2023 in Review

Cresset Asset Management sold out of Danimer Scientific, Inc. (DNMR) in Q2 2023, closing a stake of 5,752 shares — an estimated $794K sold.

Cresset Asset Management first reported a position in DNMR in Q1 2023 and held it in 1 quarter. The position peaked at $794K in Q1 2023. 148 funds tracked by Wall St. Rank hold DNMR as of Q2 2023.

  • Cresset Asset Management reported no remaining Danimer Scientific, Inc. position as of Q2 2023 after selling out during the quarter.
  • Cresset Asset Management sold 5,752 Danimer Scientific, Inc. shares in Q2 2023, an estimated $794K.
  • Cresset Asset Management first reported a position in Danimer Scientific, Inc. in Q1 2023 and held it in 1 quarter.
  • Cresset Asset Management's Danimer Scientific, Inc. position peaked at $794K in Q1 2023.
  • 148 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2023.

Based on Cresset Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.